Free Trial

Capital Fund Management S.A. Sells 8,270 Shares of Relx Plc (NYSE:RELX)

Relx logo with Computer and Technology background

Capital Fund Management S.A. reduced its position in Relx Plc (NYSE:RELX - Free Report) by 28.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 20,545 shares of the technology company's stock after selling 8,270 shares during the period. Capital Fund Management S.A.'s holdings in Relx were worth $933,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CENTRAL TRUST Co raised its position in shares of Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after purchasing an additional 529 shares during the period. Versant Capital Management Inc acquired a new position in Relx in the 4th quarter valued at about $31,000. Sierra Ocean LLC bought a new position in Relx in the 4th quarter valued at about $43,000. Brown Brothers Harriman & Co. lifted its position in Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after acquiring an additional 662 shares during the last quarter. Finally, Private Trust Co. NA boosted its holdings in shares of Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after acquiring an additional 199 shares during the period. Institutional investors own 15.02% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on RELX. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. StockNews.com lowered shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Redburn Atlantic began coverage on Relx in a research note on Wednesday, January 8th. They issued a "buy" rating for the company. Finally, The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Buy".

Check Out Our Latest Stock Analysis on RELX

Relx Trading Up 2.0 %

Shares of RELX traded up $1.03 during mid-day trading on Tuesday, reaching $53.10. 1,299,940 shares of the company were exchanged, compared to its average volume of 718,841. The business has a 50 day simple moving average of $49.41 and a two-hundred day simple moving average of $48.09. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The stock has a market capitalization of $98.28 billion, a PE ratio of 28.55, a PEG ratio of 2.73 and a beta of 0.84. Relx Plc has a 52 week low of $40.25 and a 52 week high of $53.15.

Relx Increases Dividend

The business also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be given a dividend of $0.5586 per share. This is an increase from Relx's previous semi-annual dividend of $0.23. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, May 9th. Relx's dividend payout ratio is currently 59.68%.

Relx Profile

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Further Reading

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines